Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines
暂无分享,去创建一个
H. Cooper | J. Morrissey | C. Bayliss | Luke R. Green | E. Mirkes | R. Borrow | J. Lucidarme | A. A. Akinduko | S. Clark | C. Cayrou
[1] M. Pizza,et al. Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment. , 2017, The Lancet. Infectious diseases.
[2] H. Lavender,et al. Thermoregulation of Meningococcal fHbp, an Important Virulence Factor and Vaccine Antigen, Is Mediated by Anti-ribosomal Binding Site Sequences in the Open Reading Frame , 2016, PLoS pathogens.
[3] P. Balmer,et al. Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®) , 2016, Postgraduate medicine.
[4] K. Jansen,et al. Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distribution. , 2016, The Journal of infection.
[5] R. Rappuoli,et al. Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined , 2016, Proceedings of the National Academy of Sciences.
[6] J. Morrissey,et al. Men B: lack of coverage or vaccine failure? , 2016, The Lancet.
[7] V. Saliba,et al. The introduction of the meningococcal B (MenB) vaccine (Bexsero®) into the national infant immunisation programme--New challenges for public health. , 2015, The Journal of infection.
[8] J. Bray,et al. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study , 2015, The Lancet. Infectious diseases.
[9] D. Medini,et al. Bexsero® chronicle , 2014, Pathogens and global health.
[10] A. Deghmane,et al. Genetic Diversity and Levels of Expression of Factor H Binding Protein among Carriage Isolates of Neisseria meningitidis , 2014, PloS one.
[11] R. Borrow,et al. Genotypic Analysis of Meningococcal Factor H-Binding Protein from Non-Culture Clinical Specimens , 2014, PloS one.
[12] Koichiro Tamura,et al. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.
[13] S. Ladhani,et al. Added value of PCR-testing for confirmation of invasive meningococcal disease in England. , 2013, The Journal of infection.
[14] R. Rappuoli,et al. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. , 2013, The Lancet. Infectious diseases.
[15] C. Genco,et al. Fur-Mediated Global Regulatory Circuits in Pathogenic Neisseria Species , 2012, Journal of bacteriology.
[16] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[17] M. Maiden,et al. The effect of iron availability on transcription of the Neisseria meningitidis fHbp gene varies among clonal complexes , 2012, Microbiology.
[18] Martin C. J. Maiden,et al. BIGSdb: Scalable analysis of bacterial genome variation at the population level , 2010, BMC Bioinformatics.
[19] R. Rappuoli,et al. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines , 2010, Proceedings of the National Academy of Sciences.
[20] L. Harrison,et al. Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates. , 2010, Vaccine.
[21] V. Scarlato,et al. Expression of Factor H Binding Protein of Meningococcus Responds to Oxygen Limitation through a Dedicated FNR-Regulated Promoter , 2009, Journal of bacteriology.
[22] D. Granoff,et al. The modular architecture of meningococcal factor H-binding protein. , 2009, Microbiology.
[23] R. Rappuoli,et al. Factor H-Binding Protein Is Important for Meningococcal Survival in Human Whole Blood and Serum and in the Presence of the Antimicrobial Peptide LL-37 , 2008, Infection and Immunity.
[24] S. Ram,et al. Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen. , 2008, The Journal of infectious diseases.
[25] David H Perlman,et al. The Meningococcal Vaccine Candidate GNA1870 Binds the Complement Regulatory Protein Factor H and Enhances Serum Resistance , 2006, The Journal of Immunology.
[26] R. Rappuoli,et al. Effect of Neisseria meningitidis Fur Mutations on Global Control of Gene Transcription , 2006, Journal of bacteriology.
[27] Jeannette Adu-Bobie,et al. Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870 , 2003, The Journal of experimental medicine.
[28] T. A. Hall,et al. BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .